FindTrial
Sign In

Efficacy of Royal jelly in women with premenstrual syndrome: A randomized controlled pilot study

Efficacy of Royal jelly in women with premenstrual syndrome: A randomized controlled pilot study - Efficacy of Royal jelly in women with premenstrual syndrome

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000009282
Enrollment
72
Registered
2013-01-01
Start date
2013-01-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PMS

Interventions

Control (placebo) Royal jelly 8T/day

Sponsors

Research Institute of Traditional Asian Medicine, Kinki University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: PMS symptoms (moderate to severe PMS or PMDD) Regular menstrual cycles (25-38 days)

Exclusion criteria

Exclusion criteria: Severe complication (liver disease, kidney disease, heart disease, lung disease, blood disease, malignancy, etc.) Asthma, food allergy Psychiatric disease

Design outcomes

Primary

MeasureTime frame
Severity of PMS/PMDD—

Secondary

MeasureTime frame
Severity of PMS symptoms Salivary cortisol Salivary amylase—

Countries

Japan

Contacts

Public ContactTakashi Takeda

Research Institute of Traditional Asian Medicine, Kinki University Women's health

take@med.kindai.ac.jp072-366-0221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026